Aspen’s Interim Results for the six months ended 31 December 2022 and Results presentation reminder
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
(“Aspen” or “the Company”)
ASPEN’S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2022 AND RESULTS
PRESENTATION REMINDER
Shareholders are advised that Aspen intends releasing its results for the six months ended 31 December
2022 on the JSE Stock Exchange News Service on Wednesday, 1 March 2023. This will be followed by a live
presentation to the investment community, in respect of these results, at 08h30 (SAST) on Thursday, 2
March 2023, that will be hosted at the Radisson Blu Hotel Waterfront, Cape Town.
Interested stakeholders are also invited to watch the live presentation online by accessing the webcast link:
https://www.corpcam.com/Aspen02032023
The slides accompanying the presentation will be available on the Aspen website, at
https://www.aspenpharma.com shortly before the commencement of the presentation on 2 March 2023.
A playback of the webcast will be made available on Aspen’s website approximately 2 hours after the
presentation.
Durban
17 February 2023
Sponsor:
Investec Bank Limited
Date: 17-02-2023 12:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.